Immix Biopharma
antibodies are currently being investigated as an outpatient therapy may at regions hospital may | Immix Biopharma
Company
Deck date
October 2023
Slide
55 of 57
Similar slides by Immix Biopharma
Investor Presentation
November 2023
Investor Presentation
November 2023
Investor Presentation
September 2023
Other recent decks by Immix Biopharma
Investor Presentation
March 2024
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies